Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Atu027 & gemcitabine in lead in safety period

   Silence Therapeutics plc

   Carcinoma, Pancreatic Ductal

   phase 2 · small molecule · completed

   1 trial →

2. Aumolertinib

   The First People's Hospital of Lianyungang

   Lung Cancer

   phase 2 · small molecule · active

   1 trial →

3. Aumolertinib Oral Tablet

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Lung Cancer Stage IV

   phase 2 · small molecule · active

   1 trial →

4. Autologous CD5 CAR T-cells

   Universal Integrated

   T-Cell Acute Lymphocytic Leukemia

   phase 2 · small molecule · active

   1 trial →

5. Autologous CD5 CAR T-cells

   The First People's Hospital of Lianyungang

   T-Cell Acute Lymphocytic Leukemia

   phase 2 · small molecule · active

   1 trial →

6. Autologous CD7 CAR T-cell

   Universal Integrated

   T-cell Acute Lymphoblastic Leukemia

   phase 2 · small molecule · active

   1 trial →

7. Autologous Tumor Infiltrating Lymphocytes MDA-TIL

   Iovance Biotherapeutics B.V.

   Malignant Solid Neoplasm

   phase 2 · mab · terminated

   1 trial →

8. Avastin /ml concentrate for Advanced non-small-cell lung ca…

   Fondazione Telethon ETS

   Advanced non-small-cell lung cancer

   phase 2 · small molecule · active

   1 trial →

9. Avastin /ml concentrate for Patients with ras-mutated metas…

   Fondazione Telethon ETS

   Patients with ras-mutated metastatIc colorectal cancer

   phase 2 · small molecule · active

   1 trial →

10. Avastin 25 mg/ml concentrate for solution for infusion.

    Disc Medicine

    Barrett's esophagus, Colon carcinoma, gastrointestinal dysplasia

    phase 2 · small molecule · active

    1 trial →

11. Avelumab

    Nektar Therapeutics UK Limited

    Locally Advanced or Metastatic Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

12. Avelumab and Pepinemab

    VACCINEX, INC.

    Metastatic Pancreatic Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

13. Axitinib

    United Therapeutics Europe Ltd

    Clear-cell Metastatic Renal Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

14. Axitinib

    ADIAL PHARMACEUTICALS, INC.

    Melanoma

    phase 2 · small molecule · completed

    1 trial →

15. Axumin PET/CT

    HALOZYME THERAPEUTICS, INC.

    Prostate Cancer

    phase 2 · small molecule · completed

    1 trial →

16. Azacitidine

    Syndax Pharmaceuticals

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

17. Azacitidine Injection

    The First People's Hospital of Lianyungang

    B Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

18. Azenosertib

    Zentalis Pharmaceuticals

    Uterine Serous Carcinoma

    phase 2 · small molecule · active

    2 trials →

19. Azenosertib

    Zentalis Pharmaceuticals

    Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

20. Azenosertib

    Zentalis Pharmaceuticals

    Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

21. B-MAD chemotherapy

    Takeda

    Extranodal NK/T-cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

22. B013

    BRIGHT MINDS BIOSCIENCES INC.

    Platinum-resistant Recurrent Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

23. B10 L-BPA Injection

    Heron Therapeutics

    Malignant Brain Tumors

    phase 2 · small molecule · active

    1 trial →

24. B1931036

    Pfizer Australia Pty Ltd

    Acute Lymphoblastic Leukemia (ALL)

    phase 2 · small molecule · active

    1 trial →

25. BAX69 + infusional 5-FU/LV

    Takeda

    Metastatic Colorectal Cancer

    phase 2 · mab · terminated

    1 trial →

26. BAX69 Single-Route Arm

    Takeda

    Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites

    phase 2 · mab · terminated

    1 trial →

27. BAY 1841788 for Hormone Naive Prostate Cancer

    Ningbo Cancer Hospital

    Hormone Naive Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

28. BAY 3713372 Bayer for MTAP-deleted Solid Tumors

    Bayer AG

    MTAP-deleted Solid Tumors

    phase 2 · small molecule · active

    1 trial →

29. BAY 73-4506, AVELUMAB

    The George Institute

    Adult patients with advanced or metastatic solid tumors

    phase 2 · small molecule · active

    1 trial →

30. BAY 73-4506, BAY 734506

    Bayer AG

    Solid malignant tumors

    phase 2 · small molecule · active

    1 trial →

31. BAY2757556 (Larotrectinib, Vitrakvi)

    Bayer HealthCare AG

    Solid Tumors Harboring NTRK Fusion

    phase 2 · small molecule · completed

    1 trial →

32. BB-1701-G000-205

    Eisai Co.,

    HER2 positive or HER2-low metastatic breast cancer

    phase 2 · other · active

    1 trial →

33. BB-401

    Benitec Biopharma

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

34. BBI-20201001

    Bolt Biotherapeutics

    Advanced HER2-Expressing Solid Tumors.

    phase 2 · small molecule · active

    1 trial →

35. BC1 cell line

    BriaCell Therapeutics

    Breast Cancer

    phase 2 · mab · active

    1 trial →

36. BCG (50mg/instillation) + N-803 (400 μg/instillation)

    Immunitybio Ireland Limited

    Non-muscle Invasive Bladder Cancer

    phase 2 · mab · active

    1 trial →

37. BCMA CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma, Plasma Cell Leukemia

    phase 2 · mab · active

    1 trial →

38. BCX-1777

    Biocryst

    Leukemia, Lymphocytic

    phase 2 · small molecule · completed

    1 trial →

39. BCX1777-Tio-05-202

    Biocryst

    Leukemia

    phase 2 · small molecule · terminated

    1 trial →

40. BDB001

    Eikon Therapeutics

    Tumor, Solid

    phase 2 · small molecule · completed

    1 trial →

41. BDC-1001

    Bolt Biotherapeutics

    HER2-positive Solid Tumors

    phase 2 · small molecule · terminated

    1 trial →

42. BDC-1001

    Bolt Biotherapeutics

    Metastatic Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

43. BDC-1001, PERTUZUMAB

    Bolt Biotherapeutics

    HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–POSITIVE METASTATIC BREAST CANCER

    phase 2 · small molecule · active

    1 trial →

44. BDC-4182

    Bolt Biotherapeutics

    Gastric Cancer Adenocarcinoma Metastatic

    phase 2 · small molecule · active

    1 trial →

45. BDH-CLL-002-2022/02/14

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Lymphocytic Leukemia

    phase 2 · small molecule · active

    1 trial →

46. BEAM-201

    Beam Therapeutics

    Lymphoblastic Lymphoma

    phase 2 · mab · active

    1 trial →

47. BEVACIZUMAB, ATEZOLIZUMAB

    Pari Pharma GmbH

    liver transplanted patients with advanced hepatocellular carcinoma

    phase 2 · small molecule · active

    1 trial →

48. BFH-NCRTPD

    BEONE MEDICINES AUS PTY LTD

    Colorectal Neoplasms

    phase 2 · other · active

    1 trial →

Frequently asked questions